DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Bakhshi S, Batra A, Biswas B, Dhawan D, Paul R, Sreenivas V.
Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial.
Support Care Cancer 2015;
23 (11) 3229-3237
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.